Business Context and Reporting Period
Company: Alpha Pro Tech, Ltd.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and nine months ended September 30, 2002
Business Overview: The Company manufactures and distributes disposable masks, shields, shoe covers, apparel, and wound care products. Primary markets include medical, dental, industrial safety, and clean room sectors, predominantly in the United States. Operations are segmented into Apparel, Mask and Eye Shields, and Extended Care (Fleece/Pet Beds).
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2002 |
Nine Months Ended Sep 30, 2002 |
|---|---|---|
| Sales | $5,013,000 | $16,021,000 |
| Gross Margin | $2,533,000 (50.5%) | $8,029,000 (50.1%) |
| Net Income | $362,000 | $1,451,000 |
| Diluted EPS | $0.02 | $0.06 |
| Cash and Equivalents | $2,243,000 | $2,243,000 (Balance Sheet) |
| Working Capital | $7,184,000 | $7,184,000 |
| Operating Cash Flow | N/A | $1,961,000 |
| Total Debt (Notes Payable) | $459,000 | $459,000 |
Note: Total Debt includes current portion ($141,000) and long-term portion ($318,000) of notes payable, plus capital leases ($1,000 current).
Material Changes vs. Prior Period
- Profitability Surge: Net income for the quarter increased 258.4% to $362,000 from $101,000 in the prior year quarter. For the nine-month period, net income rose 117.5% to $1,451,000 from $667,000.
- Revenue Decline: Consolidated sales decreased slightly by 1.1% ($56,000) for the quarter and 3.0% ($487,000) for the nine months compared to 2001. The decline is attributed to a slowdown in the Semiconductor clean room market.
- Margin Expansion: Gross profit margins improved significantly from 42.3% to 50.5% (quarter) and 42.8% to 50.1% (nine months). Management attributes this to increased manufacturing in China.
- Expense Management: Selling, general, and administrative (SG&A) expenses were flat for the quarter but decreased 3.3% for the nine months. Depreciation and amortization decreased due to the adoption of SFAS No. 142, which eliminated goodwill amortization.
- Share Repurchases: The Company repurchased 505,502 shares for $443,000 during the nine-month period, bringing the total buyback to 1,383,400 shares at a cost of $1,479,000.
Outlook, Risks, and Management Commentary
- Market Outlook: Management expects a slow recovery in the Semiconductor clean room market over the next several months. Conversely, the Pharmaceutical market is expanding, and the Dental market is expected to strengthen following the hiring of a dedicated sales representative.
- Liquidity: The Company maintains a $4,301,000 credit facility with $2,380,000 currently unused. Management believes cash from operations and the credit facility are sufficient for working capital and capital expenditures.
- Capital Expenditures: Investing activities totaled $150,000 for the nine months. The Company expects to purchase an additional $50,000 of equipment in 2002.
- Risks: Continued weakness in the Semiconductor clean room market remains a primary risk to revenue growth. The Medical market, comprising 15% of revenue, is not considered a high-growth area.
Investor Verification Checklist
- China Manufacturing Impact: Verify the sustainability of the gross margin improvement (50%+) driven by increased production in China.
- Semiconductor Market Recovery: Monitor the timeline and magnitude of the expected recovery in the Semiconductor clean room segment, which is currently dragging down apparel sales.
- Debt Covenants: Review the terms of the $4.3M credit facility, specifically the expiration dates (Line of credit May 2004, Term note April 2003) and interest rate structures (Prime + 0.5% to 1.0%).
- Share Count Reduction: Confirm the impact of the ongoing stock repurchase program on future earnings per share (EPS) dilution.
- Inventory Levels: Note that inventories increased by $490,000 during the nine-month period; verify if this aligns with demand forecasts or indicates potential obsolescence risks.